National Institute of General Medical Sciences; Notice of Closed Meetings, 28122 [2021-11039]
Download as PDF
<![CDATA[
28122
Federal Register / Vol. 86, No. 99 / Tuesday, May 25, 2021 / Notices
Facility and Building System Upgrades
Support for the Regional Biocontainment
Laboratories (G20—Clinical Trial Not
Allowed).
Date: June 30, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G42A, Rockville, MD
20852, (240) 669–5069, lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 19, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10965 Filed 5–24–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Centers of Biomedical
Research Excellence (COBRE) Phase 1
Applications.
Date: July 13–14, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Nina Sidorova, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institutes of General
VerDate Sep<11>2014
18:09 May 24, 2021
Jkt 253001
Medical Sciences, National Institutes of
Health, 45 Center Drive, Room 3AN18,
Bethesda, MD 20814, 301–402–2783,
sidorova@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS Pathway to
Independence Award K99/R00 Applications.
Date: July 15, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Rebecca H. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, 45 Center
Drive, Bethesda, MD 20892, 301–594–2771,
johnsonrh@nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS Support of
Competitive Research (SCORE) Award
Applications.
Date: July 19, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Saraswathy Seetharam,
Ph.D., Scientific Review Officer, Office
Scientific Review, National Institute of
General Medical Sciences, National Institutes
Health, 45 Center Drive, Room 3AN12C,
Bethesda, MD 20892, 301–594–2763,
seetharams@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: May 20, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–11039 Filed 5–24–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2021–0016; OMB No.
1660–0086]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; National Flood
Insurance Program—Mortgage
Portfolio Protection Program (MPPP);
Ask the Advocate Web Form
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: 60-Day notice of revision and
request for comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA), as part of
its continuing effort to reduce
paperwork and respondent burden,
invites the general public to take this
opportunity to comment on a revision of
a previously approved information
collection. In accordance with the
Paperwork Reduction Act of 1995, this
notice seeks comments concerning an
amendment to a currently-approved
collection of information related to the
National Flood Insurance Program
(NFIP), Mortgage Portfolio Protection
Program (MPPP), which is an option
that companies participating in the
NFIP can use to bring their mortgage
loan portfolios into compliance with the
flood insurance purchase requirements.
This notice seeks comments concerning
the collection of information related to
the Office of the Flood Insurance
Advocate (OFIA).
DATES: Comments must be submitted on
or before July 26, 2021.
ADDRESSES: To avoid duplicate
submissions to the docket, please
submit comments at
www.regulations.gov under Docket ID
FEMA–2021–0016. Follow the
instructions for submitting comments.
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at www.regulations.gov, and will
include any personal information you
provide. Therefore, submitting this
information makes it public. You may
wish to read the Privacy and Security
Notice that is available via a link on the
homepage of www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: For
information related to the NFIP
Mortgage Portfolio Protection Program
SUMMARY:
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 86, Number 99 (Tuesday, May 25, 2021)]
[Notices]
[Page 28122]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11039]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of Centers of Biomedical
Research Excellence (COBRE) Phase 1 Applications.
Date: July 13-14, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Video Meeting).
Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer,
Office of Scientific Review, National Institutes of General Medical
Sciences, National Institutes of Health, 45 Center Drive, Room
3AN18, Bethesda, MD 20814, 301-402-2783, [email protected].
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of NIGMS Pathway to
Independence Award K99/R00 Applications.
Date: July 15, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Video Meeting).
Contact Person: Rebecca H. Johnson, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Natcher Building,
Room 3AN18C, 45 Center Drive, Bethesda, MD 20892, 301-594-2771,
[email protected].
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Review of NIGMS Support of
Competitive Research (SCORE) Award Applications.
Date: July 19, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892 (Video Meeting).
Contact Person: Saraswathy Seetharam, Ph.D., Scientific Review
Officer, Office Scientific Review, National Institute of General
Medical Sciences, National Institutes Health, 45 Center Drive, Room
3AN12C, Bethesda, MD 20892, 301-594-2763, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859, Biomedical Research and
Research Training, National Institutes of Health, HHS)
Dated: May 20, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-11039 Filed 5-24-21; 8:45 am]
BILLING CODE 4140-01-P
